Jump to main content
Jump to site search
PLANNED MAINTENANCE Close the message box

Scheduled maintenance work on Wednesday 22nd May 2019 from 11:00 AM to 1:00 PM (GMT).

During this time our website performance may be temporarily affected. We apologise for any inconvenience this might cause and thank you for your patience.


Issue 3, 2019
Previous Article Next Article

Improved druggability of gambogic acid using core–shell nanoparticles

Author affiliations

Abstract

Gambogic acid (GA) is a natural antitumor drug candidate with advantages of broad-spectrum activity, low toxicity and multiple mechanisms. Its clinical application is hindered, however, by low aqueous solubility, instability and poor pharmacokinetic properties. In this research, core–shell hybrid nanoparticles have been developed to improve the druggability of GA. The nanoparticles are composed of a benzylamidated poly(γ-glutamic acid) (BzPGA) derivative as a core material and an amphiphilic hyaluronic acid derivative grafted with all-trans retinoic acid (HA-C6-ATRA) as a shell material. Through π–π stacking interactions, GA is encapsulated into BzPGA to form the “core” of the hybrid nanoparticle and the “shell” is formed by HA-C6-ATRA with a π–π stacking mediated “molecular fence”. The nanovehicle, with sub 100 nm size, provides almost 100% encapsulation efficiency, a good protective effect and a sustained release profile for GA. A series of evaluations suggest that the core–shell nanoparticles provide a stable aqueous injection formulation (I), improved stability (II), prolonged circulation time and conferred tumor targeting properties (III) for GA. As a result, the anti-tumor activity of GA is significantly enhanced without causing higher toxicity, indicating that the designed nanoplatform dramatically improves the druggability of GA. This study may also provide inspiration for drug development research.

Graphical abstract: Improved druggability of gambogic acid using core–shell nanoparticles

Back to tab navigation

Supplementary files

Publication details

The article was received on 19 Sep 2018, accepted on 17 Dec 2018 and first published on 19 Dec 2018


Article type: Paper
DOI: 10.1039/C8BM01154K
Biomater. Sci., 2019,7, 1028-1042

  •   Request permissions

    Improved druggability of gambogic acid using core–shell nanoparticles

    F. Liu, X. Huang, L. Han, M. Sang, L. Hu, B. Liu, B. Duan, P. Jiang, X. Wang, Z. Qiao, C. Ma, W. Liu, J. Liu, F. Feng and W. Qu, Biomater. Sci., 2019, 7, 1028
    DOI: 10.1039/C8BM01154K

Search articles by author

Spotlight

Advertisements